この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/10/41 分で読めます
New Animal Drugs; Change of Sponsor's Address; Monensin; Spinosad; Tilmicosin
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) during August 2012 and to reflect a change of sponsor's address for Baxter Healthcare Corp. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →